COVID-19 has quickly become a public health problem worldwide, and treatment for this new disease is needed
Registration
More evidence has shown that hydroxychloroquine and chloroquine cannot prevent COVID-19
acid
A few small uncontrolled trials and several
4 The experts and researchers have been trying hard to find rapid diagnostic and therapeutic agents to counter the disease
However, this medicine is not used to treat severe or complicated malaria
The possible activity of 4
Patients who had had symptoms of Covid-19 for up to 7 days and had at least one risk factor for disease progression were randomly assigned to receive ivermectin (400 μg per kilogram of body This review describes the history, mechanisms, pharmacokinetics, therapeutic applications, and safety profile of hydroxychloroquine as an immunomodulatory and antiviral agent
3-9 Hydroxychloroquine was adopted into routine care for hospitalized adults with COVID-19 at many hospitals
Despite several studies designed to evaluate the efficacy of chloroquine and hydroxychloroquine in the treatment of coronavirus disease 2019 (COVID-19), there is still doubt about the effects of At the end of the trial, 8 participants from the hydroxychloroquine group (3
Memorandum explaining basis for revocation of emergency use authorization for emergency use of chloroquine phosphate Food and Drug Administration, July 1, 2020, FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart There is currently no clear data to inform clinical guidance on the use, dosing, or duration for COVID-19 treatment